Sentence examples for differentiation problem from inspiring English sources

The purpose of this paper is uncertainty evaluation in a target differentiation problem.

In contrast to other schemes, this approach exploits SCTP features, message-oriented and multistreaming, to cope with loss differentiation problem.

The present findings bear implications for the lineage differentiation problem.

In past years studies to resolve the lineage differentiation problem have underscored the importance of antigen dose, the degree of inflammation at the time of priming, and the frequency of naïve precursors [10].

Since in many systems protection appears to be preferentially mediated by T cells of the central memory type [6], [7], [8], [9], it is important to understand when and how lineage differentiation begins (the lineage differentiation problem).

Hv1 expression might be impaired in PLB-985 X CGD cells for the following reasons: a) PLB-985 X CGD clone has a general differentiation problem, b) PLB-985 X CGD is a clone in which Hv1 expression is diminished in a Nox2 independent manner or c) normal Nox2 expression is required for normal Hv1 expression.

His experience in creating multidisciplinary strategies and tactics to solve research, design, and differentiation problems has repeatedly lead to positive results.

The cellular differentiation experiments show the necessity of qualitatively different kinds of basic field elements (i.e., singular and regular elements) to achieve sufficient flexibility to solve the differentiation problems satisfactorily.

Interestingly, both CDX2 and SOX2 deficiency lead to implantation failure of the blastocyst secondary to trophoectoderm differentiation problems [ 4– 6].

We first prove the existence of approximate solutions for a sum-type fractional integro-differential problem via Caputo differentiation.

Although there is still no clear consensus on the benefit of culture expanded ADE-MSCs over freshly isolated SVFs, additional in vitro manipulation steps used to create extensive numbers of ADE-MSCs in autologous setting are costly, require regulatory approval, and could lead to contamination and early-differentiation problems diminishing therapeutic potency.